Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4606)
All Articles published online
|
Nov 21, 2012 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Efrati C, Nicolini G, Cannaviello C, O’Sed NP, Valabrega S. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i43/6250.htm |
| Number | Citing Articles |
| 1 |
V De Francesco, A Zullo, R Manta, M Pavoni, IM Saracino, G Fiorini, F Giostra, G Monti, D Vaira. First-line therapies for H. pylori infection in Italy: a pooled-data analysis. Acta Gastro Enterologica Belgica 2022; 85(2): 295 doi: 10.51821/85.2.9680
|
| 2 |
Sotirios D Georgopoulos, Vasilios Papastergiou, Stylianos Karatapanis. Treatment ofHelicobacter Pyloriinfection: optimization strategies in a high resistance era. Expert Opinion on Pharmacotherapy 2015; 16(15): 2307 doi: 10.1517/14656566.2015.1084503
|
| 3 |
R Garcés-Duran, S Kindt, K Kotilea, S François, G Rasschaert, A Smet, B Hauser, A Driessen, M Nkuize, A Burette, V Lamy, P Bontems, H Louis, R Ntounda, V.Y. Miendje Deyi, F Mana. Belgian consensus for Helicobacter pylori management 2023. Acta Gastro Enterologica Belgica 2023; 86(1): 74 doi: 10.51821/86.1.11327
|
| 4 |
Mohamed H. Emara, Salem Y. Mohamed, Hesham R. Abdel-Aziz. Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial. Therapeutic Advances in Gastroenterology 2014; 7(1): 4 doi: 10.1177/1756283X13503514
|
| 5 |
Sadia Alvi, Aqeel Javeed, Bushra Akhtar, Ali Sharif, Muhammad Furqan Akhtar. Probiotics for cure of Helicobacter pylori infection: A review. International Journal of Food Properties 2017; 20(10): 2215 doi: 10.1080/10942912.2016.1233432
|
| 6 |
Costantino Dargenio, Vanessa Nadia Dargenio, Francesca Bizzoco, Flavia Indrio, Ruggiero Francavilla, Fernanda Cristofori. Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection. Medicina 2021; 57(7): 733 doi: 10.3390/medicina57070733
|
| 7 |
M. J. Salas-Jara, E. A. Sanhueza, A. Retamal-Díaz, C. González, H. Urrutia, A. García. Probiotic Lactobacillus fermentum UCO-979C biofilm formation on AGS and Caco-2 cells and Helicobacter pylori inhibition. Biofouling 2016; 32(10): 1245 doi: 10.1080/08927014.2016.1249367
|
| 8 |
Marco Vega-Sagardía, Jorge Rocha, Katia Sáez, Carlos T. Smith, Cristian Gutierrez-Zamorano, Apolinaria García-Cancino. Encapsulation, with and without oil, of biofilm forming Lactobacillus fermentum UCO-979C strain in alginate-xanthan gum and its anti- Helicobacter pylori effect. Journal of Functional Foods 2018; 46: 504 doi: 10.1016/j.jff.2018.04.067
|
| 9 |
Melike Arslan, Necati Balamtekin, Armağan Günal. Efficacy of a novel sequential treatment regimen containing bismuth forHelicobacter pylorieradication in Turkish children. Helicobacter 2020; 25(6) doi: 10.1111/hel.12757
|
| 10 |
Amit K. Tyagi, Sahdeo Prasad. Commentary: Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis. Frontiers in Microbiology 2015; 6 doi: 10.3389/fmicb.2015.00433
|
| 11 |
Javier P. Gisbert, Javier Alcedo, Javier Amador, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Luis Fernández-Salazar, Emili Gené, Ángel Lanas, Alfredo J. Lucendo, Javier Molina-Infante, Olga P. Nyssen, A. Pérez-Aisa, Ignasi Puig. V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterología y Hepatología 2022; 45(5): 392 doi: 10.1016/j.gastrohep.2021.07.011
|
| 12 |
Po-Xing Zheng, Hsin-Yi Fang, Hsiao-Bai Yang, Nai-Yueh Tien, Ming-Cheng Wang, Jiunn-Jong Wu. Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori. Journal of Microbiology, Immunology and Infection 2016; 49(2): 168 doi: 10.1016/j.jmii.2014.04.014
|
| 13 |
Amit K. Tyagi, Sahdeo Prasad. Corrigendum: Commentary: Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01628
|
| 14 |
Vasilios Papastergiou, Sotirios D Georgopoulos, Stylianos Karatapanis. Treatment of <italic>Helicobacter pylori</italic> infection: Meeting the challenge of antimicrobial resistance. World Journal of Gastroenterology 2014; 20(29): 9898-9911 doi: 10.3748/wjg.v20.i29.9898
|
| 15 |
Javier P. Gisbert, Javier Alcedo, Javier Amador, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Luis Fernández-Salazar, Emili Gené, Ángel Lanas, Alfredo Lucendo, Javier Molina-Infante, Olga P. Nyssen, A. Pérez-Aisa, Ignasi Puig. V Spanish Consensus Conference on Helicobacter pylori infection treatment. Gastroenterología y Hepatología (English Edition) 2022; 45(5): 392 doi: 10.1016/j.gastre.2021.07.001
|
| 16 |
Debabrata Dash, Vivek Mishra, Manoj Kumar Panda, Sushil Kumar Pathak. Effects of Lactobacillus spp. on Helicobacter pylori: A Promising Frontier in the Era of Antibiotic Resistance. Probiotics and Antimicrobial Proteins 2024; doi: 10.1007/s12602-024-10396-z
|
| 17 |
György Miklós Buzás. Probiotics in gastroenterology – from a different angle. Orvosi Hetilap 2013; 154(8): 294 doi: 10.1556/OH.2013.29547
|
| 18 |
Amir Hossein Miri, Mojtaba Kamankesh, Antoni Llopis-Lorente, Chenguang Liu, Matthias G. Wacker, Ismaeil Haririan, Hamid Asadzadeh Aghdaei, Michael R. Hamblin, Abbas Yadegar, Mazda Rad-Malekshahi, Mohammad Reza Zali. The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.917184
|
| 19 |
Majid Eslami, Bahman Yousefi, Parviz Kokhaei, Ali Jazayeri Moghadas, Bizhan Sadighi Moghadam, Vahid Arabkari, Zohreh Niazi. Are probiotics useful for therapy of Helicobacter pylori diseases?. Comparative Immunology, Microbiology and Infectious Diseases 2019; 64: 99 doi: 10.1016/j.cimid.2019.02.010
|
| 20 |
Xiaofen Bai, Minjie Zhu, Yajun He, Tengyan Wang, Da Tian, Jianchang Shu. The impacts of probiotics in eradication therapy of Helicobacter pylori. Archives of Microbiology 2022; 204(12) doi: 10.1007/s00203-022-03314-w
|
| 21 |
Anthony O'Connor, Javier Molina‐Infante, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori Infection 2013. Helicobacter 2013; 18(s1): 58 doi: 10.1111/hel.12075
|
| 22 |
Luis Vitetta, Rachel Manuel, Joyce Zhou, Anthony Linnane, Sean Hall, Samantha Coulson. The Overarching Influence of the Gut Microbiome on End-Organ Function: The Role of Live Probiotic Cultures. Pharmaceuticals 2014; 7(9): 954 doi: 10.3390/ph7090954
|